The tumor recall response of antitumor immunity primed by a live, recombinant Listeria monocytogenes vaccine comprises multiple effector mechanisms.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Clinical Immunology

• Publication date

  2001-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1006/CLIM.2000.4987PMID 11237558
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interleukin 12 and tumor necrosis factor a are costimulators of interferon y production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist

  2005cited by this paper
• NK Markers Are Expressed on a High Percentage of Virus-Specific CD8+ and CD4+ T Cells1

  2000cited by this paper
• Interleukin (Il)-4 Is a Major Regulatory Cytokine Governing Bioactive IL-12 Production by Mouse and Human Dendritic Cells

  2000cited by this paper
• Monoclonal Antibody Supernatant and Ascites Fluid Production

  2000cited by this paper
• Tumor stroma.

  1999cited by this paper
• CD4 T Cells and Their Role in Antitumor Immune Responses

  1999cited by this paper
• T Helper Cell Type 1–associated and Cytotoxic T Lymphocyte–mediated Tumor Immunity Is Impaired in Interleukin 4–deficient Mice

  1999cited by this paper
• Perforin-Deficient CD8+ T Cells Provide Immunity to Listeria monocytogenes by a Mechanism That Is Independent of CD95 and IFN-γ but Requires TNF-α

  1998cited by this paper
• Specific T Helper Cell Requirement for Optimal Induction of Cytotoxic T Lymphocytes against Major Histocompatibility Complex Class II Negative Tumors

  1998cited by this paper
• The Central Role of CD4+ T Cells in the Antitumor Immune Response

  1998cited by this paper
• Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis.

  1998cited by this paper
• Perforin-deficient CD8+ T cells provide immunity to Listeria monocytogenes by a mechanism that is independent of CD95 and IFN-gamma but requires TNF-alpha.

  1998cited by this paper
• Transient control of interleukin-4-producing natural killer T cells in the livers of Listeria monocytogenes-infected mice by interleukin-12

  1997cited by this paper
• The cytokine stew and innate resistance to L. monocytogenes

  1997cited by this paper
• Involvement of NK1+ CD4- CD8- alphabeta T cells and endogenous IL-4 in non-MHC-restricted rejection of embryonal carcinoma in genetically resistant mice.

  1997cited by this paper
• Interleukin‐4 and listeriosis

  1997cited by this paper
• Requirement for Vα14 NKT Cells in IL-12-Mediated Rejection of Tumors

  1997cited by this paper
• Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors.

  1997cited by this paper
• Studies in listeriosis show the strong symbiosis between the innate cellular system and the T‐cell response

  1997influential reference
• Developmental pathways of dendritic cells in vivo: distinct function, phenotype, and localization of dendritic cell subsets in FLT3 ligand-treated mice.

  1997cited by this paper
• IL-4 secretion by CD4+ NK1+ T cells induces monocyte chemoattractant protein-1 in early listeriosis.

  1997cited by this paper
• LPS induces NK1.1+ alpha beta T cells with potent cytotoxicity in the liver of mice via production of IL-12 from Kupffer cells.

  1996cited by this paper
• Liver NK1.1+ CD4+ alpha beta T cells activated by IL-12 as a major effector in inhibition of experimental tumor metastasis.

  1996cited by this paper
• Control of natural killer cell-mediated innate resistance against the intracellular pathogen Listeria monocytogenes by gamma/delta T lymphocytes

  1996cited by this paper
• Apoptosis of macrophages induced by liposome-mediated intracellular delivery of clodronate and propamidine.

  1996cited by this paper
• Differential roles for IL-12 in the maintenance of immune responses in infectious versus autoimmune disease.

  1996cited by this paper
• Induction of cell-mediated immune responses to human immunodeficiency virus type 1 Gag protein by using Listeria monocytogenes as a live vaccine vector.

  1995cited by this paper
• Interleukin‐4‐producing CD4+ NK1.1+ TCRα/βintermediate liver lymphocytes are down‐regulated by Listeria monocytogenes

  1995cited by this paper
• Interleukin-4-producing CD4+ NK1.1+ TCR alpha/beta intermediate liver lymphocytes are down-regulated by Listeria monocytogenes.

  1995cited by this paper
• A recombinant Listeria monocytogenes vaccine expressing a model tumour antigen protects mice against lethal tumour cell challenge and causes regression of established tumours

  1995cited by this paper
• Regression of established tumors in mice mediated by the oral administration of a recombinant Listeria monocytogenes vaccine.

  1995cited by this paper
• Inhibition of angiogenesis in vivo by interleukin 12.

  1995cited by this paper
• Activation of gamma delta T cells for production of IFN-gamma is mediated by bacteria via macrophage-derived cytokines IL-1 and IL-12.

  1995cited by this paper
• Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens.

  1994cited by this paper
• Delivery of a viral antigen to the class I processing and presentation pathway by Listeria monocytogenes

  1994cited by this paper
• CD8+ T cell‐mediated protection against an intracellular bacterium by perforin‐dependent cytotoxicity

  1994cited by this paper
• Transforming growth factor-beta-mediated down-regulation of antitumor cytotoxicity of spleen cells from MOPC-315 tumor-bearing mice engaged in tumor eradication following low-dose melphalan therapy.

  1994cited by this paper
• Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications.

  1994cited by this paper
• Fate of Listeria monocytogenes in murine macrophages: evidence for simultaneous killing and survival of intracellular bacteria

  1994cited by this paper
• Administration of anti-granulocyte mAb RB6-8C5 impairs the resistance of mice to Listeria monocytogenes infection.

  1994cited by this paper
• NK1.1+ CD4+ CD8‐ thymocytes with specific lymphokine secretion

  1993cited by this paper
• Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages.

  1993cited by this paper
• Different roles of alpha beta and gamma delta T cells in immunity against an intracellular bacterial pathogen.

  1993cited by this paper
• Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist.

  1993cited by this paper
• Different roles of αβ and γδ T cells in immunity against an intracellular bacterial pathogen

  1993cited by this paper
• Neutrophils are involved in acute, nonspecific resistance to Listeria monocytogenes in mice

  1993cited by this paper
• Administration of anti-IL-4 monoclonal antibody 11B11 increases the resistance of mice to Listeria monocytogenes infection.

  1992cited by this paper
• An eosinophil-dependent mechanism for the antitumor effect of interleukin-4.

  1992cited by this paper
• A protective role of gamma/delta T cells in primary infection with Listeria monocytogenes in mice

  1992cited by this paper
• Induction of a cellular immune response to a foreign antigen by a recombinant Listeria monocytogenes vaccine.

  1992cited by this paper
• Inhibition of tumor-specific cytotoxic T-lymphocyte responses by transforming growth factor beta 1.

  1992cited by this paper
• Transforming growth factor-beta-induced inhibition of T cell function. Susceptibility difference in T cells of various phenotypes and functions and its relevance to immunosuppression in the tumor-bearing state.

  1991cited by this paper
• Current protocols in immunology

  1991cited by this paper
• Neutrophil-mediated dissolution of infected host cells as a defense strategy against a facultative intracellular bacterium

  1991cited by this paper
• Effects of purified anti-Lyt-2 mAb treatment on murine listeriosis: comparative roles of Lyt-2+ and L3T4+ cells in resistance to primary and secondary infection, delayed-type hypersensitivity and adoptive transfer of resistance.

  1990influential reference
• Actin filaments and the growth, movement, and spread of the intracellular bacterial parasite, Listeria monocytogenes

  1989cited by this paper
• The cell surface of mouse dendritic cells: FACS analyses of dendritic cells from different tissues including thymus.

  1989cited by this paper
• T-cell subsets in delayed-type hypersensitivity, protection, and granuloma formation in primary and secondary Listeria infection in mice: superior role of Lyt-2+ cells in acquired immunity

  1988influential reference
• Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha

  1987cited by this paper
• Therapy of murine leukemia with cyclophosphamide and immune Lyt-2+ cells: cytolytic T cells can mediate eradication of disseminated leukemia.

  1986cited by this paper
• Origin and regulation of tumor-associated macrophages: the role of tumor-derived chemotactic factor.

  1986cited by this paper
• Therapy of disseminated murine leukemia with cyclophosphamide and immune Lyt-1+,2- T cells. Tumor eradication does not require participation of cytotoxic T cells

  1985cited by this paper
• A monoclonal antibody specific for mouse dendritic cells.

  1982cited by this paper
• Eradication of disseminated murine leukemia by chemoimmunotherapy with cyclophosphamide and adoptively transferred immune syngeneic Lyt-1+2- lymphocytes

  1981cited by this paper
• Identification of ganglio-N-tetraosylceramide as a new cell surface marker for murine natural killer (NK) cells.

  1980cited by this paper
• Tumor induction relationships in development of transplantable cancers of the colon in mice for chemotherapy assays, with a note on carcinogen structure.

  1975cited by this paper

• Bacteria in cancer therapy: beyond immunostimulation

  2018cites this paper
• Therapeutic live vaccines as a potential anticancer strategy

  2012cites this paper
• Listeria monocytogenes as a vector for anti-cancer therapies.

  2010cites this paper
• Live, attenuated strains of Listeria and Salmonella as vaccine vectors in cancer treatment

  2010cites this paper
• Live Vaccine Carriers

  2010cites this paper
• Multiple effector mechanisms induced by recombinant Listeria monocytogenes anticancer immunotherapeutics.

  2009cites this paper
• Bacterial Pathogen Hyper-Antigen Secreting Intracytosolic Responses Following Immunization with a Stimulation of Enhanced CD 8 T Cell

  2008cites this paper
• Vaccination strategies for malignant diseases

  2008cites this paper
• Stimulation of Enhanced CD8 T Cell Responses Following Immunization with a Hyper-Antigen Secreting Intracytosolic Bacterial Pathogen1

  2008cites this paper
• Cancer immunotherapy using Listeria monocytogenes and listerial virulence factors

  2008cites this paper
• Investigating the potential of the Metastasis Associated Antigen 1 (MTA1) for cancer immunotherapy in a murine model

  2007cites this paper
• Engineering bacterial vectors for delivery of genes and proteins to antigen-presenting cells.

  2007cites this paper
• Award Number : W 81 XWH-041-0338 TITLE : Evaluation of Listeria monocytogenes Based Vaccines for HER-2 / Neu in Mouse Transgenic Models of Breast Cancer

  2006cites this paper
• Control of cancers by combining antiangiogenesis and cancer immunotherapy.

  2005cites this paper
• Subdominant Epitopes in the FVB/N Mouse Immunogenicity of HER-2/neu and Reveals Enhances the Listeria monocytogenes Fusion to Listeriolysin O and Delivery by

  2005cites this paper
• Fusion to Listeriolysin O and Delivery by Listeria monocytogenes Enhances the Immunogenicity of HER-2/neu and Reveals Subdominant Epitopes in the FVB/N Mouse1

  2005cites this paper
• Immunotherapy of cancer for the elderly patient: does allogeneic bone marrow transplantation after nonmyeloablative conditioning provide a new option?

  2004cites this paper
• Rational approaches to immune regulation

  2003cites this paper
• Immunotherapy of Cancer by Active Vaccination: Does Allogeneic Bone Marrow Transplantation after Non-Myeloablative Conditioning Provide a New Option?

  2003cites this paper
• Tumor immunity within the central nervous system stimulated by recombinant Listeria monocytogenes vaccination.

  2002cites this paper
• Live bacteria as the basis for immunotherapies against cancer

  2002cites this paper
• Analysis of the immunologic response generated by Ad.IFN-beta during successful intraperitoneal tumor gene therapy.

  2002cites this paper
• IFN- Cells Requires Tumor Responsiveness to T + Angiogenesis by Tumor-Infiltrating CD4 -Dependent Inhibition of Tumor g IFN-Gregory

  2001cites this paper
• Tolerance or Immunity to a Tumor Antigen Expressed in Somatic Cells Can Be Determined by Systemic Proinflammatory Signals at the Time of First Antigen Exposure1

  2001cites this paper
• Two Listeria monocytogenes Vaccine Vectors That Express Different Molecular Forms of Human Papilloma Virus-16 (HPV-16) E7 Induce Qualitatively Different T Cell Immunity That Correlates with Their Ability to Induce Regression of Established Tumors Immortalized by HPV-161

  2001cites this paper
• IFN-gamma-dependent inhibition of tumor angiogenesis by tumor-infiltrating CD4+ T cells requires tumor responsiveness to IFN-gamma.

  2001cites this paper
• Immortalized by HPV-16 to Induce Regression of Established Tumors Immunity That Correlates with Their Ability Induce Qualitatively Different T Cell Human Papilloma Virus-16 (HPV-16) E7 That Express Different Molecular Forms of Vaccine Vectors Listeria monocytogenes Two

  2001cites this paper
• Regulation of tumor growth by IFN-gamma in cancer immunotherapy.

  2001cites this paper
• Papilloma Virus-16 ( HPV-16 ) E 7 Induce Express Different Molecular Forms of Human Vaccine Vectors That Listeria monocytogenes Two

  2001cites this paper
• IFN-γ-Dependent Inhibition of Tumor Angiogenesis by Tumor-Infiltrating CD4+ T Cells Requires Tumor Responsiveness to IFN-γ1

  2001cites this paper
• Regulation of tumor growth by IFN-γ in cancer immunotherapy

  2001cites this paper